<unk>  is a drug with low toxicity, it causes no irritation. Sometimes it results in dyspnoea, or shortness of breath, and it could result in hypoglycaemia. In case of pregnancy, there are more severe toxic effects as tested in rats. At a dose of 2100 mg/kg, there were cases of fetal death, developmental abnormalities in the central nervous system, the eye and ear, and craniofacial abnormalities (including face and nose) 7 to 13 days after conception. At a lower dose (1050 mg/kg) it resulted in fetotoxicity (no death, but e.g. stunted fetus), and developmental abnormalities in the musculoskeletal system. For several rodent species the lethal dose has been investigated for several exposure routes, this is displayed in table 1. Table 1: LD50 doses for several organisms and exposure routes. Organism Exposure route Reported dose (=normalized dose) Mouse intraperitoneal 235 mg/kg Mouse intravenous 193 mg/kg Mouse oral 550 mg/kg Mouse subcutaneous 248 mg/kg Rabbit intraperitoneal 300 mg/kg Rabbit intravenous 118 mg/kg Rabbit oral 967 mg/kg Rat intraperitoneal 249 mg/kg Rat oral 500 mg/kg Rat subcutaneous 310 mg/kg
Glybuzole
Glysobuzole
Amivantamab
Lepra 
Memantine
Rilonacept
Nusinersen
Riluzole